Global Health Ventures Inc. to Develop Rapidly Acting Low Cost Nicotine Replacement Therapy
Global Health Ventures Inc. (OTCBB: GHLV) (the “Company”), a specialty pharma company focused on life style products is pleased to announce that it has started working on a new commercial product “Nico-Z”. Nico-Z is a sublingual formulation of nicotine that is incorporated through our proprietary technology to deliver the product rapidly to the blood stream. It is anticipated that Nico-Z will …
Read more on SYS-CON Media
Related Posts: